Vizgen to showcase Merscope results at AACR 2022
Life sciences company Vizgen announced that it will showcase data for understanding the tumor microenvironment from its spatial genomics platform Merscope at the American Association for Cancer Research (AACR) Annual Meeting, held April 8-13. Read More
Xstrahl introduces compact benchtop irradiator
Xstrahl has introduced CIX1, a benchtop irradiator designed to make radiation accessible to research labs. Read More
FDA approves Kite CAR T therapy Yescarta
The U.S. Food and Drug Administration (FDA) has approved axicabtagene ciloleuce (Yescarta), a CAR T-cell therapy manufactured by Kite, a Gilead company. Read More
Waters introduces Xevo TQ mass spectrometer
Waters has launched the new Xevo TQ (tandem quadrupole) absolute system, a high-performance, 45% smaller mass spectrometer. Read More
Genethon joins U.S. Bespoke Gene Therapy Consortium
Genethon has joined the U.S.-based Bespoke Gene Therapy Consortium launched by the Foundation for the National Institutes of Health, as part of its Accelerating Medicines Partnership program. Read More
Mission Bio appoints new chief medical officer
Life sciences company Mission Bio has announced the appointment of Dr. Todd Druley, PhD, as chief medical officer, a newly created role at Mission Bio. Read More
Genialis partners with OncXerna to improve targeted therapy
Genialis announced that its artificial intelligence software will be used to help classify patients for targeted cancer therapy using OncXerna's panel, an RNA-based pantumor biomarker. Read More
Labcorp renews strategic partnership with Medidata
Labcorp has extended its 14-year partnership with life sciences firm Medidata. The aim of the collaboration is to codevelop digital biomarkers and use them in decentralized clinical trials. Read More
Charles River acquires Explora BioLabs
Charles River Laboratories has acquired San Diego-based Explora BioLabs, a provider of contract vivarium research services. Read More
Moderna Charitable Foundation awards $5M in initial grants
Biotechnology company Moderna has announced the launch of the Moderna Charitable Foundation. Approximately $5 million in initial grants have been awarded to local and global nonprofits that support groups and causes disproportionately affected by COVD-19. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
